----item----
version: 1
id: {8856CA29-9789-4898-ACFC-9025B9762C82}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/09/22/Targovax Adds Two Board Members
parent: {DB7AFD0C-FF3A-4A4A-B0E2-6A1121FFD09B}
name: Targovax Adds Two Board Members
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 244fb55a-6040-4419-9510-8a1d80c1107b

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 31

Targovax Adds Two Board Members
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 31

Targovax Adds Two Board Members
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 663

<p>Targovax AS, a clinical stage immuno-oncology company, has appointed Eva-Lotta Allan and Diane Mellett as non-executive directors. </p><p>With over 25 years of business development experience from the biotech and life science industry, Allan is currently chief business officer at Immunocore Ltd. She has also held senior positions at Oxford Asymmetry (now Evotec), Vertex Pharmaceuticals, Ablynx and Oxford GlycoSciences (now UCB). </p><p>Mellett is currently a consultant to biotech and medical device companies and previously was general counsel for Cambridge Antibody Technology, where she led its UK and US IPOs and was also a member of the board. </p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 138

<p>Targovax AS, a clinical stage immuno-oncology company, has appointed Eva-Lotta Allan and Diane Mellett as non-executive directors. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 31

Targovax Adds Two Board Members
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150922T130001
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150922T130001
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150922T130001
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029833
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 31

Targovax Adds Two Board Members
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{202BB75B-8718-40FC-96EC-851DBBB43362}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

360520
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042454Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

244fb55a-6040-4419-9510-8a1d80c1107b
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042454Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
